3B62.1

ICD-11 MMS 2026-01

Bleeding diathesis due to thromboxane synthesis deficiency

Description

A disease caused by thromboxane synthesis deficiency. This disease is characterised by low levels of eicosanoids (lipids), abnormalities in coagulation leading to haemorrhaging. Confirmation is by identification of low levels of eicosanoids in a blood sample.

Index terms

  • Bleeding diathesis due to thromboxane synthesis deficiency

Exclusions from above levels

  • 3B12 – Von Willebrand disease
  • JA43.3 – Postpartum coagulation defects
  • 04 – Diseases of the immune system
Show allHide
  • 05 – Endocrine, nutritional or metabolic diseases
  • 18 – Complications of pregnancy, childbirth or the puerperium
  • 19 – Certain conditions originating in the perinatal period
  • 20 – Congenital malformations, deformations or chromosomal abnormalities
  • 22 – Injury, poisoning or certain other consequences of external causes
  • http://id.who.int/icd/entity/1000704511 – Human immunodeficiency virus disease
  • JB64.1 – Other diseases of the blood or blood-forming organs or certain disorders involving the immune mechanism complicating pregnancy, childbirth or the puerperium

Sibling codes

  • 3B62.0 – Inherited qualitative platelet defects
  • 3B62.2 – Isolated thrombocytopenia
  • 3B62.3 – Dense granule disease
  • 3B62.4 – Alpha-delta dense granule deficiency
  • 3B62.Y – Other specified qualitative platelet defects
  • 3B62.Z – Qualitative platelet defects, unspecified

Foundation entity

Bleeding diathesis due to thromboxane synthesis deficiency – http://id.who.int/icd/entity/1676860885

Part of: 3B62: Qualitative platelet defects › 03: Diseases of the blood or blood-forming organs